Teaching evidence-based complementary and alternative medicine: 4. Appraising the evidence for papers on therapy

Journal of Alternative and Complementary Medicine

Volumn 8, Issue 5, 2002, Pages 673-679

  Wilson, Kumanan ^a   Mills, Edward J ^b   Ross, Cory ^b   Guyatt, Gordon ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b CANADIAN COLLEGE OF NATUROPATHIC MEDICINE   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE MEDICINE; ARTICLE; CLINICAL PRACTICE; CLINICAL RESEARCH; EVIDENCE BASED MEDICINE; PEER REVIEW; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZATION; VALIDATION PROCESS;

CHILD; CLINICAL COMPETENCE; COMPLEMENTARY THERAPIES; EDUCATION, MEDICAL, CONTINUING; EVIDENCE-BASED MEDICINE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; OTITIS MEDIA; PROBIOTICS; QUALITY ASSURANCE, HEALTH CARE; TEACHING; UNITED STATES;

EID: 0036803536     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/107555302320825192     Document Type: Article

References (22)

1. Dean ME. A homeopathic origin for placebo controls: "An invaluable gift of God." Altern Ther Health Med 2000;6:58-66.
2. Devereaux PJ, Manns BJ, Ghali WA, Quan H, Lacchetti C, Montori VM, Bhandari M, Guyatt GH. Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials. JAMA 2001;285:2000-2003.
3. Evidence-Based Medicine Working Group. A new approach to teaching the practice of medicine: Evidence-Based Medicine Working Group. JAMA 1992;268:2420-2425.
4. Farr BM, Gwaltney JM, Jr. The problems of taste in placebo matching: An evaluation of zinc gluconate for the common cold. J Chronic Dis 1987;40:875-879.
5. Grimes D, Schulz KF. Cohort studies: Marching towards outcomes. Lancet 2002;359:341-345.
6. Guyatt G, Rennie D. Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice. Chicago: American Medical Association, 2002.
7. Hollis S, Campbell F. What is meant by intention-to-treat analysis? Survey of published randomized controlled trials. BMJ 1999;319:670-674.
8. Kernan WN, Viscoli CM, Makuch RW, Brass LM, Horwitz RI. Stratified Randomization for Clinical Trials. J Clin Epidemiol 1999;52:19-26.
9. Kunz R, Oxman AD. The unpredictability paradox: Review of empirical comparisons of randomised and non-randomised clinical trials. BMJ 1998;317:1185-1190.
10. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, Tugwell P, Klassen TP. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998;352:609-613.
11. Overall JE. Drop-outs and a random regression model. J Biopharm Stat 1997;7:383-402.
12. Randolph AG, Haynes RB, Wyatt JC, Cook DJ, Guyatt GH. Users' Guides to the Medical Literature: XVIII. How to use an article evaluating the clinical impact of a computer-based clinical decision support system. JAMA 1999;282:67-74.
13. Roos K, Hakansson EG, Holm S. Effect of recolonisation with "interfering" alpha streptococci on recurrences of acute and secretory otitis media in children: Randomised placebo controlled trial. BMJ 2001;322:210-212.
14. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-412
15. Schulz KF, Grimes DA. Sample size slippages in randomised trials: Exclusions and the lost and wayward. Lancet 2002a;359:781-785.
16. Schulz KF, Grimes DA. Unequal group sizes in randomised trials: Guarding against guessing. Lancet 2002b;359:966-970.
17. Schulz KF, Grimes DA. Generation of allocation sequences in randomised trials: Chance, not choice. Lancet 2002c;359:515-519.
18. Stenström C, Ingvarsson L. Otitis-prone children and controls: A study of possible predisposing factors. 1. Heredity, family background and perinatal period. Acta Otolaryngol (Stockh) 1997;17:87-93.
19. Torgerson DJ, Roberts C. Understanding controlled trials: Randomisation methods. Concealment. BMJ 1999a;319:375-376.
20. Torgerson DJ, Roberts C. Understanding controlled trials: Baseline imbalance in randomised controlled trials. BMJ 1999b;319:185.
21. Vickers AJ, de Craen AJ. Why use placebos in clinical trials? A narrative review of the methodological literature. J Clin Epidemiol 2000;53:157-161.
22. Whiting-O'Keefe QE, Henke C, Simborg DW. Choosing the correct unit of analysis in Medical Care experiments. Med Care 1984;22:1101-1114.